Sonova Audiological Care Denmark Aps
Hans Edvard Teglers Vej 5, 1, 2920 Charlottenlund, CVR 16753181
Rank Profit for the year
Rank in industry
1/74
"Top 10%"
Rank in Denmark
18,018/322,119
"Top 10%"
Top management Top 3
| Peter Brøgger Andreasen 3 | CEO |
| Tina Gath 3 | Director |
| Anette Pia Andersen 2 | Director |
Legal owners Top 3
| 100% | Sonova AG |
Rights certificate
Selskabet tegnes af to direktører i forening.
Company information based on CVR
| Name | Sonova Audiological Care Denmark Aps |
|---|---|
| Alternate names | Audio Consult Slagelse Aps, Audiodan Høreklinik Aps, Audionova Aps, Audionova Hørecenter Aps, Auri Hørecenter Aps, Center for Bedre Hørelse Aps, Den Private Høreklinik Aps, Hørecenter Horsens Aps, Høreteknik, Vejle/Viby Aps, Næstved Hørecenter Aps, Sonova Retail Denmark Aps Show more |
| CVR | 16753181 |
| Address | Hans Edvard Teglers Vej 5, 1, 2920 Charlottenlund |
| Industry | Retail sale of medical and orthopaedic goods in specialized stores [477400] |
| Established | 01-01-1993 (29 yr) |
| Company type | Limited Corporation (APS) |
| Number of employees | 173 (man years:160) |
| Advertising protection | No |
| Auditor | Ey Godkendt Revisionspartnerselskab since 30-06-2020 |
| Financial statement period | 01-04 to 31-03 |
| Company capital | 440,000 DKK 420,000 DKK (19-03-2020 - 27-03-2022) 400,000 DKK (10-02-2020 - 18-03-2020) 380,000 DKK (15-03-2019 - 09-02-2020) 360,000 DKK (29-01-2018 - 14-03-2019) 340,000 DKK (21-03-2017 - 28-01-2018) |
| Articles of assoc. last | 28-03-2022 |
Member of industries
- Retail sale of medical and orthopaedic goods in specialized storesNACE6 containing 137 comp.
- Retail sale of other goods in specialized storesNACE3 containing 14,303 comp.
- Retail trade, except of motor vehicles and motorcyclesNACE2 containing 40,364 comp.
- Wholesale and retail trade, repair of motor vehicles and motorcyclesNACE1 containing 79,486 comp.
Purpose
Selskabets formål er handel med, behandling af patienter med og undervisning vedrørende høreapparater, investering i andre selskaber, der driver virksomhed hermed samt anden i forbindelse hermed stående virksomhed.
Financial Statement
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Currency/unit | 000' DKK | 000' DKK | 000' DKK |
| Revenue | 186,586 -6% | 198,743 +8% | 184,496 +13% |
| Gross Profit | 89,098 +13% | 79,008 +16% | 68,305 +11% |
| Profit for the year | 6,500 - | -3,840 - | -17,774 - |
| Equity | 35,129 +23% | 28,629 +173% | 10,469 +220% |
| Total Assets | 105,169 0% | 105,527 +3% | 102,496 +23% |
Mangement review
Management’s reviewFinancial highlights
Development in activities and financial mattersThe revenue for the year is DKK 186,586 thousand against DKK 198,743 thousand last year. The results after tax are DKK 6,500 thousand against DKK -3,840 thousand last year. The result is in line with the Managements expectation.In 2020/21 the Company has received DKK 7,354 thousand in Government grants related t compensation for the impact of Covid-19. This has been part of the relief for the Company. Although not fully in line with initial expectations due to impact of Covid-19 from mid March 2020, where our clinics were closed for approximately 2 months, the overall performance and results of our activities are considered to be satisfying. Successfully we have continued our value positioning focus and we have strengthened our internal balance in the dimensions of Employee engagement, Customer centricity and Business results further.Increased competition from local ear, nose and throat doctors has led to a decrease in the total private market. Furthermore main competitors are showing strong indications and actions to grow. Despite challenges in the market the Company has managed to protect and gain shares in the private market.StrategySonova Audiological Care Denmark ApS offers a complete range of digital hearing instruments, wireless FM systems and personal hearing protection.The development and manufacture of hearing instruments take place primarily in Stäfä, (Switzerland) where the Sonova Group has its headquarters and in Kitchener (Ontario, Canada), whereas wireless communication systems are manufactured in Murten (Switzerland).Product innovation, customer focus and cost management are the three pillars in the strategy.Financial risksOperating risksThe effects of fluctuations in the economy (expansion or recession) are expected to be limited for the Company, due to the fact that the dependency on the economic cycle is not very high. The Company acts in a healthcare market, where the dependency on the reimbursement system is large. Changes in legislation can lead to significant impact on the result of the Company.Financial risksThe Company holds sufficient liquidity to ensure the fulfillment of all planned payment obligations. The amount of the liquidity reserve is regularly reviewed and adjusted as necessary according to circumstances.Exchange rate risksThe Company is not significantly exposed to currency rate risks, since purchases take place in EUR and DKK while sales only take place in DKK. The Company does not hold any reserves in other currencies.Credit risksThe Company is not exposed to significant credit risks. The larger portion of the outstandings are Regions and/or Municipalities.
Development in activities and financial mattersThe revenue for the year is DKK 186,586 thousand against DKK 198,743 thousand last year. The results after tax are DKK 6,500 thousand against DKK -3,840 thousand last year. The result is in line with the Managements expectation.In 2020/21 the Company has received DKK 7,354 thousand in Government grants related t compensation for the impact of Covid-19. This has been part of the relief for the Company. Although not fully in line with initial expectations due to impact of Covid-19 from mid March 2020, where our clinics were closed for approximately 2 months, the overall performance and results of our activities are considered to be satisfying. Successfully we have continued our value positioning focus and we have strengthened our internal balance in the dimensions of Employee engagement, Customer centricity and Business results further.Increased competition from local ear, nose and throat doctors has led to a decrease in the total private market. Furthermore main competitors are showing strong indications and actions to grow. Despite challenges in the market the Company has managed to protect and gain shares in the private market.StrategySonova Audiological Care Denmark ApS offers a complete range of digital hearing instruments, wireless FM systems and personal hearing protection.The development and manufacture of hearing instruments take place primarily in Stäfä, (Switzerland) where the Sonova Group has its headquarters and in Kitchener (Ontario, Canada), whereas wireless communication systems are manufactured in Murten (Switzerland).Product innovation, customer focus and cost management are the three pillars in the strategy.Financial risksOperating risksThe effects of fluctuations in the economy (expansion or recession) are expected to be limited for the Company, due to the fact that the dependency on the economic cycle is not very high. The Company acts in a healthcare market, where the dependency on the reimbursement system is large. Changes in legislation can lead to significant impact on the result of the Company.Financial risksThe Company holds sufficient liquidity to ensure the fulfillment of all planned payment obligations. The amount of the liquidity reserve is regularly reviewed and adjusted as necessary according to circumstances.Exchange rate risksThe Company is not significantly exposed to currency rate risks, since purchases take place in EUR and DKK while sales only take place in DKK. The Company does not hold any reserves in other currencies.Credit risksThe Company is not exposed to significant credit risks. The larger portion of the outstandings are Regions and/or Municipalities.
30-06-2021